Bart Friedman
Lead Independent DirectorMr. Bart Friedman, J.D. is Chair of the Board at Giant Eagle, Inc. from March 2023 and its Lead Independent Director. He has been a Senior Partner at Cahill Gordon & Reindel LLP since 1980. Mr. Friedman’s practice focuses on corporate governance investigations and advisory and crisis advisory. Mr. Friedman was a Partner of Cahill Gordon & Reindel LLP and became Senior Counsel as of January 2017. He serves as Chairman of the Board of the Sanford C. Bernstein Mutual Funds. He served as a Vice Chairman of Allied World Assurance Company Holdings, AG since July 2006. He has been a Director of Emerging Markets Value, Tax-Managed International and AllianceBernstein Blended Style Series - Tax-Managed International Portfolio since 2005. He served as the Lead Independent Director and Director of Allied World Assurance Company Holdings, AG since January 2008 and March 3, 2006 respectively. He has been Independent Director at Ovid Therapeutics Inc. since November 23, 2015 and serves as its Lead Independent Director. He serves as a Director of Sanford Funds in Fund Complex. He serves as a Director of Lincoln Center for the Performing Arts Inc. Mr. Friedman serves as a Trustee of The Brookings Institution and Institute Of International Education, Inc. Mr. Friedman served as a Director of The Mountain School of Milton Academy. Earlier in his career, Mr. Friedman worked at the Securities and Exchange Commission, initially as Special Counsel and later as Assistant Director. He is Treasurer of the Smithsonian’s Cooper-Hewitt Museum. He has broad experience advising financial institutions, global corporations and boards of directors of publicly held companies. Mr. Friedman earned his AB from Long Island University. He earned his J.D. at Harvard Law School and was on the research faculty of Harvard Business School.
Positions
- Company NameOvid Therapeutics Inc.Stock CodeOVIDPositionLead Independent DirectorColleagues
- JMJeremy Max LevinCo-Founder & Executive Chairman
- MAMargaret AlexanderCEO, President & Director
- JAJeffrey A. RonaAdvisor
- CRCharles Ross CarterCFO, Principal Financial Officer, Principal Accounting Officer & Secretary
- ZZZhong ZhongChief Scientific Officer
- BGBarbara G. DuncanIndependent Director
- RSRobert S. LangerChairman of the Scientific & Clinical Advisory Board
